Menopausal hormone therapy and new-onset diabetes in the French E3N cohort

被引：0
|
作者：
de Lauzon-Guillain, B. [1 ,2 ]
Fournier, A. [2 ]
Fabre, A. [2 ]
Simon, N. [2 ]
Mesrine, S. [2 ]
Boutron-Ruault, M. -C.
Balkau, B. [1 ]
Clavel-Chapelon, F. [2 ]
机构：
[1] INSERM, U780, Villejuif, France
[2] INSERM, Eri 20, Villejuif, France
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
611
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [1] Menopausal Hormone Therapy and Risk of Cholecystomy in the French E3N Prospective Cohort Study
    Racine, Antoine
    Bijon, Anne
    Mesrine, Sylvie
    Clavel-Chapelon, Francoise
    Carbonnel, Franck
    Boutron-Ruault, Marie-Christine
    GASTROENTEROLOGY, 2012, 142 (05) : S99 - S99
  • [2] Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohort
    B. de Lauzon-Guillain
    A. Fournier
    A. Fabre
    N. Simon
    S. Mesrine
    M-C. Boutron-Ruault
    B. Balkau
    F. Clavel-Chapelon
    Diabetologia, 2009, 52 : 2092 - 2100
  • [3] Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle G,n,rale de l'Education Nationale (E3N) cohort
    de Lauzon-Guillain, B.
    Fournier, A.
    Fabre, A.
    Simon, N.
    Mesrine, S.
    Boutron-Ruault, M-C.
    Balkau, B.
    Clavel-Chapelon, F.
    DIABETOLOGIA, 2009, 52 (10) : 2092 - 2100
  • [4] Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort
    Racine, Antoine
    Bijon, Anne
    Fournier, Agnes
    Mesrine, Sylvie
    Clavel-Chapelon, Francoise
    Carbonnel, Franck
    Boutron-Ruault, Marie-Christine
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (07) : 555 - 561
  • [5] Postmenopausal hormone therapy and asthma onset in the E3N cohort
    Romieu, Isabelle
    Fabre, Alban
    Fournier, Agnes
    Kauffmann, Francine
    Varraso, Raphaelle
    Mesrine, Sylvie
    Leynaert, Benedicte
    Clavel-Chapelon, Francoise
    THORAX, 2010, 65 (04) : 292 - 297
  • [6] Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
    Agnès Fournier
    Sylvie Mesrine
    Laure Dossus
    Marie-Christine Boutron-Ruault
    Françoise Clavel-Chapelon
    Nathalie Chabbert-Buffet
    Breast Cancer Research and Treatment, 2014, 145 : 535 - 543
  • [7] Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
    Fournier, Agnes
    Mesrine, Sylvie
    Dossus, Laure
    Boutron-Ruault, Marie-Christine
    Clavel-Chapelon, Francoise
    Chabbert-Buffet, Nathalie
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (02) : 535 - 543
  • [8] Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?
    Sophie Morois
    Agnès Fournier
    Françoise Clavel-Chapelon
    Sylvie Mesrine
    Marie-Christine Boutron-Ruault
    European Journal of Epidemiology, 2012, 27 (6) : 439 - 452
  • [9] Hormone replacement therapy and risk of diabetes among women of the E3N cohort
    de Lauzon-Guillain, B.
    Fournier, A.
    Fabre, A.
    Simon, N.
    Mesrine, S.
    Boutron-Ruault, M. C.
    Balkau, B.
    Clavel-Chapelon, F.
    DIABETES & METABOLISM, 2009, 35 : A9 - A9
  • [10] Erratum to: Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
    Agnès Fournier
    Sylvie Mesrine
    Laure Dossus
    Marie-Christine Boutron-Ruault
    Françoise Clavel-Chapelon
    Nathalie Chabbert-Buffet
    Breast Cancer Research and Treatment, 2014, 147 : 225 - 225
12345